← All News
Bloomberg Markets · 1 min read

AbbVie Set to Sell $10 Billion in Bonds to Fund Apogee Deal

AbbVie Inc. has launched a $10 billion investment-grade bond sale to help fund its pending acquisition of fellow drugmaker Apogee Therapeutics Inc.

This is a summary aggregated from Bloomberg Markets. Read the complete article on the original site:

Read full article at Bloomberg Markets

More Business & Finance News

Blackstone Digital Infrastructure Trust targets 40% leverage as it deploys $2B IPO proceeds into stabilized data centers

Seeking Alpha · 17 min ago

Northrop names former Chevron investor relations head Randy Sinclair to lead IR

Seeking Alpha · 19 min ago

'Inevitable' US, Iran Will See More Volatility In Coming Months, Says Suzanne Maloney

Bloomberg Markets · 21 min ago

Launch HN: EdotEnv (YC S26) – Quant Trading RL Envs to Teach LLMs Research

Hacker News · 23 min ago

These charts suggest the S&P 500 is looking like a bargain. Take them with a grain of salt.

MarketWatch · 23 min ago

Viper targets 4.5% Q3 production growth as it raises base dividend 32% to $2

Seeking Alpha · 27 min ago